Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 12, 2026
Reporting period
Not applicable
Filed with the SEC
Mar 4, 2026
OfficerGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0000874716-26-000046
Filed / recorded
Mar 4, 2026, 2:45 AM UTC
Added to OQRO
Oct 2, 2026, 12:28 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
IDEXX LABORATORIES INC /DE
Issuer CIK
874716
Ticker
IDXX
Reporting person
Michael G Erickson
Relationship
Officer
Officer title
Executive Vice President
Security
Non-Qualified Stock Option (right-to-buy)
Table
Derivative (Table II)
Transaction date
Feb 12, 2026
Transaction code
A
Shares / units
13,667
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
13,667
Ownership form
Direct
Amendment
Yes (Form 4/A)
Footnotes from the filing
This Amendment on Form 4/A (this 'Amendment') amends the Form 4 filed on February 17, 2026 (the 'Original Form 4') solely to correct an administrative error, which resulted in the inadvertent erroneous reporting of the equity awards granted to the reporting person on February 12, 2026. Specifically, Table II of the Original Form 4 incorrectly reported that 6,319 restricted stock units (of which 1,580 restricted stock units were deferred) were granted to the reporting person on February 12, 2026, which did not occur. Instead, as reported in this Amendment, a non-qualified stock option to purchase 13,667 shares of Issuer common stock and an incentive stock option to purchase 162 shares of Issuer common stock were granted to the reporting person on February 12, 2026, with an exercise price equal to the closing price of the Issuer's common stock on that day. This Amendment does make any other changes to the Original Form 4.
Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2027.
